Trials / Recruiting
RecruitingNCT03570450
Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
Regenerative Stem Cell Therapy for Stroke in Europe 1
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 95 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adipose derived Stem Cell | 4 doses |
| OTHER | placebo | placebo |
Timeline
- Start date
- 2018-06-02
- Primary completion
- 2025-07-01
- Completion
- 2027-07-01
- First posted
- 2018-06-27
- Last updated
- 2023-07-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03570450. Inclusion in this directory is not an endorsement.